Martindale Pharma Revenue and Competitors

Brentwood, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Martindale Pharma's estimated annual revenue is currently $148.5M per year.(i)
  • Martindale Pharma's estimated revenue per employee is $201,000

Employee Data

  • Martindale Pharma has 739 Employees.(i)

Martindale Pharma's People

NameTitleEmail/Phone
1
Head Sales, Specilaity ProductsReveal Email/Phone
2
Head Customer Service OperationsReveal Email/Phone
3
PA to manufacturing directorReveal Email/Phone
4
Regulatory Affairs Compliance Officer and Packaging DevelopmentReveal Email/Phone
5
Quality Assurance OfficerReveal Email/Phone
6
Senior Quality Assurance OfficerReveal Email/Phone
7
Outsourcing ManagerReveal Email/Phone
8
Addiction Healthcare Development ManagerReveal Email/Phone
9
HSE and Facilities ManagerReveal Email/Phone
10
Healthcare Development Manager , Consultant, Nutritional Therapist, Coach & Peer MentorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Martindale Pharma?

keywords:N/A

N/A

Total Funding

739

Number of Employees

$148.5M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Martindale Pharma News

2022-04-17 - Investor Alert - The M&A Class Action Firm is Investigating the ...

Antares Pharma, Inc. (ATRS), relating to its proposed acquisition by ... He has also been selected by Martindale-Hubbell as a 2017-2021 Top...

2022-04-17 - Global Timolol Maleate Eye Drop Market Analysis 2028 ...

Martindale Pharma, an Ethypharm Group Company; FDC International Ltd; Zentiva; Brown & Burk UK Ltd. The product type examined in this study...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$308.1M8155%N/A
#2
$163.4M8161%$125M
#3
$154.5M849-9%N/A
#4
$354.9M939N/AN/A
#5
$278.7M948N/AN/A